Syntal at CPHI Milan 2026 – Visit Us at Booth 8C90!

We are pleased to announce that Syntal will be participating in one of the most prestigious global events for the chemical and pharmaceutical industries – CPHI Milan 2026. The event will take place from October 6th to 8th, 2026, at the Fiera Milano exhibition center in Italy.
Attending CPHI provides us with a fantastic opportunity to showcase our core competencies and well-established position in the field of advanced chemical synthesis. As a Polish manufacturer with over 40 years of experience, we successfully combine our own R&D capabilities with scale-up and commercial production capacities.
During the exhibition, our experts will be available to discuss collaboration opportunities and the technological potential of Syntal in key areas, including:
 
    • CDMO Services / Contract Manufacturing: Comprehensive project execution – from laboratory process optimization to full-scale commercial production.
    • Advanced Organic Synthesis: Complex, multi-step custom organic synthesis and development of niche chemical structures tailored to specific requirements.
    • Fine Chemicals & Intermediates: Supply of high-purity chemical products and advanced intermediates under strict quality standards.
    • R&D and Tech Transfer: Scaling-up processes, technology transfer, and solving complex organic chemistry synthesis challenges backed by our dedicated research team.

CPHI is the perfect venue for direct dialogue, exchanging professional experience, and building long-term business partnerships. We warmly invite our current partners as well as companies seeking a reliable and flexible CDMO provider to visit us on-site.
 
📍 You can find us at Booth 8C90.
 
To ensure the full availability of our technical and business experts, we highly recommend scheduling your appointment in advance. To arrange a convenient time for a meeting, please contact us directly via email at: biuro@syntal.com.pl.
 
See you in Milan!
The Syntal Team

 
Meet Syntal at CPHI Milan at stand 8C90!

Other news

Syntal has implemented the cGMP synthesis of CAS 32384-65-9 as an essential building block for active pharmaceutical ingredients, specifically gliflozins (SGLT2 inhibitors). Compliance with cGMP ensures high purity and batch reproducibility.

Increasing production capacity of n-hexatriacontane (CAS 630-06-8) – portfolio development and supply stability for the chemical industry

1-S-OCTYL-β-D-THIOGLUCOPYRANOSIDE (CAS 85618-21-9) – a new compound in our portfolio and its significance for chemistry and biotechnology

2,5,6-Trimethylbenzoxazole (CAS 19219-98-8) – Product Spotlight at Syntal Chemicals